| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |